Literature DB >> 15943036

Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland.

T Daa1, N Kaku, K Kashima, I Nakayama, S Yokoyama.   

Abstract

We evaluated the expression of beta-catenin, E-cadherin, and cyclin-D1 in 23 cases of adenoid cystic carcinoma (ACC) of the salivary gland. We detected beta-catenin on the cell membranes in all ACCs, but its distribution was irregular, as compared to that on normal structures. In three out of the 23 cases, beta-catenin was detected in the nuclei, as well as on cell membranes. Polymerase chain reaction (PCR) and direct sequencing revealed a missense mutation in one case in which beta-catenin had been detected in the nuclei of tumor cells. We also detected E-cadherin on cell membranes with a similar irregular distribution to that of beta-catenin. In 11 cases (almost 48%) of ACC, cyclin D1 was localized in cell nuclei but there was no correlation with the nuclear staining of the beta-catenin. Our results suggest that disturbances in the distribution of beta-catenin and E-cadherin might affect the morphology ofACC and that a small fraction of cases of ACC are characterized by a mutation in the beta-catenin gene, which is associated with the nuclear accumulation of the product of this gene but does not affect the transcription of the gene for cyclin-D1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943036

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  9 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Wnt/beta-catenin signaling in oral tissue development and disease.

Authors:  F Liu; S E Millar
Journal:  J Dent Res       Date:  2010-03-03       Impact factor: 6.116

3.  Expression patterns of WNT/β-CATENIN signaling molecules during human tooth development.

Authors:  Bingmei Wang; Hanliang Li; Ying Liu; Xin Lin; Yao Lin; Ye Wang; Xuefeng Hu; Yanding Zhang
Journal:  J Mol Histol       Date:  2014-03-20       Impact factor: 2.611

4.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.

Authors:  Sven Schneider; Dietmar Thurnher; Rudolf Seemann; Markus Brunner; Lorenz Kadletz; Bahil Ghanim; Klaus Aumayr; Gregor Heiduschka; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-24       Impact factor: 2.503

5.  Evaluation of immunohistochemical expression of E-cadherin in pleomorphic adenoma and adenoid cystic carcinoma.

Authors:  Bhavani Nagendra Sangala; Vandana Raghunath; Pratibha Kavle; Anish Gupta; Swati Shrikant Gotmare; Venkata Subhash Andey
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

6.  Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.

Authors:  Tsuyoshi Saito; Hiroyuki Mitomi; Abdukadir Imamhasan; Takuo Hayashi; Keiko Mitani; Michiko Takahashi; Yoshiaki Kajiyama; Takashi Yao
Journal:  Virchows Arch       Date:  2014-01-26       Impact factor: 4.064

7.  Primary intraosseous adenoid cystic carcinoma of the mandible: histopathological and immunohistochemical analysis.

Authors:  Román Carlos-Bregni; Elisa C Vidaurre; Ana Carolina Netto; Jorge E León; Oslei P Almeida
Journal:  Pathol Oncol Res       Date:  2009-04-21       Impact factor: 3.201

8.  A comparative study between mixed-type tumours from human salivary and canine mammary glands.

Authors:  Marisa C L S Genelhu; Sérgio V Cardoso; Helenice Gobbi; Geovanni D Cassali
Journal:  BMC Cancer       Date:  2007-11-28       Impact factor: 4.430

9.  Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasion.

Authors:  Min Jung Jung; Jong-Lyel Roh; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim; Sang-Wook Lee; Kyung-Ja Cho
Journal:  Diagn Pathol       Date:  2013-10-21       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.